These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15373148)

  • 1. Opinion: The high cost of low drug prices.
    Franks B
    N J Med; 2004; 101(7-8):56, 55. PubMed ID: 15373148
    [No Abstract]   [Full Text] [Related]  

  • 2. The war on drug--prices: states are taking up the fight to reduce prescription drug costs.
    Boulard G
    State Legis; 2002 Mar; 28(3):12-7. PubMed ID: 11873811
    [No Abstract]   [Full Text] [Related]  

  • 3. 3 New England states prescribe innovative ways to cut drug prices.
    Carlson B
    Manag Care; 2000 Dec; 9(12):17-8. PubMed ID: 11188356
    [No Abstract]   [Full Text] [Related]  

  • 4. Opinion: price controls on prescription drugs.
    Franks B
    N J Med; 2004 Apr; 101(4):56, 55. PubMed ID: 15103791
    [No Abstract]   [Full Text] [Related]  

  • 5. Reining in Medicare drug costs a challenge.
    Fulton A
    AHIP Cover; 2008; 49(3):12, 91, 93. PubMed ID: 18533383
    [No Abstract]   [Full Text] [Related]  

  • 6. The Affordable Prescription Drugs Act: a solution for today's high prescription drug prices.
    Pinzone JD
    J Law Health; 2001-2002; 16(1):145-68. PubMed ID: 14650775
    [No Abstract]   [Full Text] [Related]  

  • 7. Maine Rx: the act to establish fairer prescription drug prices.
    Pingree C
    Minn Med; 2001 Jan; 84(1):48-9. PubMed ID: 11202525
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmaceuticals: pharmaceutical cost controls.
    Seay M; Lee LL
    Issue Brief Health Policy Track Serv; 2007 Jan; ():1-22. PubMed ID: 17357250
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmaceuticals: pharmaceutical cost control measures: year end report-2002.
    Kammer C
    Issue Brief Health Policy Track Serv; 2002 Dec; ():1-14. PubMed ID: 12856689
    [No Abstract]   [Full Text] [Related]  

  • 10. Medicare drug prices and the deficit.
    Frank RG
    N Engl J Med; 2011 Nov; 365(18):1657-9. PubMed ID: 21995337
    [No Abstract]   [Full Text] [Related]  

  • 11. The pharmaceutical industry--to whom is it accountable?
    Holmer AF
    N Engl J Med; 2000 Nov; 343(19):1415; discussion 1417. PubMed ID: 11183877
    [No Abstract]   [Full Text] [Related]  

  • 12. A drug benefit: the necessary prescription for Medicare.
    Rother J
    Health Aff (Millwood); 1999; 18(4):20-2. PubMed ID: 10425839
    [No Abstract]   [Full Text] [Related]  

  • 13. Controlling prescription drug costs: regulation and the role of interest groups in Medicare and the Veterans Health Administration.
    Frakt AB; Pizer SD; Hendricks AM
    J Health Polit Policy Law; 2008 Dec; 33(6):1079-106. PubMed ID: 19038872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Trading with the Enemy Act of 1917 and synthetic drugs: relieving scarcity, controlling prices, and establishing pre-market licensing controls.
    Cooper D
    Pharm Hist; 2005; 47(2):47-61. PubMed ID: 16447341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How can states provide affordable pharmaceuticals to the underserved?
    Zara J
    J Health Care Poor Underserved; 2006 Nov; 17(4):808-20. PubMed ID: 17242532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceuticals and medical devices: cost savings.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-20. PubMed ID: 19297717
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmaceuticals: pharmaceutical cost controls--2005. End of Year Issue Brief.
    Seay M; Varma P
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-20. PubMed ID: 16708455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-27. PubMed ID: 18345555
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmaceutical pricing. Health care purchasing at risk.
    Betz R
    Health Syst Rev; 1995; 28(1):21-3. PubMed ID: 10139753
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug price controls will cripple research and development, pharmaceutical executives tell Congress.
    Am J Hosp Pharm; 1994 May; 51(9):1132, 1135-6, 1139. PubMed ID: 8042629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.